Imricor (ASX:IMR) cardiac innovation goes global
January 27, 2023Cardiac technology company Imricor has partnered with GE HealthCare to allow real-time iCMR ablations on the GE MRI platform.
Realtime iCMR Cardiac Ablations can help improve the treatment of Atrial Flutter, a heart rhythm disorder (arrhythmia) caused by problems with your heart’s electrical system.
Atrial Flutter affects your heart’s upper chambers (atria) and causes a heartbeat that is too fast. The regular but fast rhythm makes atrial Flutter different from other arrhythmias. Left untreated can increase your risk of stroke or heart failure.
Imricor’s new NorthStar-MR 3D Mapping System is intended to operate on the GE HealthCare MRI platform as it does on the Siemens MRI platform, offering physicians a similar user experience no matter which of the two MRI systems they are operating intending to allow GE HealthCare MRI sites to participate in upcoming clinical trials.
“We are thrilled at the prospect of expanding the portfolio of MRI scanners that support Advantage-MR and NorthStar-MR technology,” CEO and Chair Steve Wedan said.
“The addition of GE HealthCare will give physicians and hospitals significantly more flexibility to use the MRI hardware of their choice, when providing real-time iCMR ablations for their patients.
“We are grateful to our existing customers who have embraced our real-time iCMR ablation technology and look forward to making the benefits of this technology even more widely available.”
Price Action
The Company’s ASX-listed shares are 27c at pre-Market Open.
Memorandum of Understanding
Under the terms of the MOU, GE HealthCare and Imricor intend to collaborate to interface Imricor’s Advantage-MR EP Recorder/Stimulator and NorthStar-MR 3D Mapping System with GE HealthCare MRI scanners. A successful collaboration will enable cardiac electrophysiology (EP) ablation procedures guided by real-time MRI, using Imricor’s catheters and other disposable devices, to be performed on the GE HealthCare MRI platform. The collaboration with GE HealthCare would expand Imricor’s potential to interface with GE HealthCare’s new and currently installed MRI scanners.
About Imricor
Imricor Medical Systems, Inc. (ASX:IMR) is a leading developer of innovative MRI-compatible medical devices which can be used to carry out real-time iCMR cardiac ablation procedures. Headquartered in the US, Imricor seeks to make a meaningful impact on patients, healthcare professionals, and healthcare facilities worldwide by increasing success rates and bringing down the overall costs of cardiac ablation procedures.
Fundamental Data
Please note the following valuable information before using this website.
Independent Research
Market Open Australia is intended to be used only for educational and informative purposes, and any information on this website should not be taken as investment advice or guidance. It is important to conduct your own research before making any investment decisions, which should be based on your own investment needs and personal circumstances. Any investment decisions based on information contained on this website should be taken in line with independent financial advice from a qualified professional or should be independently researched and verified.
